The results make the case for surgeons to be more involved in secondary prevention, especially with the PCSK9 inhibitor.

The TRIUMPH-2 and SYNCHRONIZE-2 studies show both novel agents to be highly effective, but some questions remain.

BARCELONA, Spain—The DEDICATE-DZHK6 trial comparing TAVI with SAVR in low-to-intermediate-risk German patients with aortic ...

The expert consensus decision pathway goes beyond the guidelines to provide practice advice around BP management.

The observational Swedish data need to be further explored but may have identified a new screening target in stroke ...

A postapproval study and a subgroup analysis of complex patients show high efficacy rates for the two limus-eluting ...

From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

Two new observational studies add to the growing evidence base on cardiovascular risks associated with hormone replacement ...

Observational studies from Spain, Italy, and the United States help paint a clearer picture of a growing field.

ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of ...